Results of a new study published in the journal Pharmacotherapy indicated that patients diagnosed with migraine headaches saw a significant decrease in the frequency of their headaches when they received treatment with medical marijuana.
The study results were announced by the Skaggs School of Pharmacy and Pharmaceutical Services at the University of Colorado Anschutz Medical Campus.
The study examined patients diagnosed with migraines and treated between January 2010 and September 2014. It found that the frequency of migraines dropped from 10.4 to 4.6 migraine headaches per month. This decrease is considered statistically and clinically significant.
The study was one of the first to indicate a drop in migraine frequency for patients using medical marijuana.
Of the 121 patients in the study, 103 reported a decrease in their monthly migraines. 15 indicated the same number of migraines, and three reported an increase in their migraines.
Professor Laura Borgelt, in commented on the study results, stated, “There was a substantial improvement for patients in their ability to function and feel better.”
The study researchers found that inhaled marijuana appeared to be the favorite for treating acute migraines and that eating edible marijuana products helped prevent the headaches.
The exact mechanism for marijuana relieving migraines is not yet fully understood. Borgelt indicated that cannabinoid receptors are found through the human body, including the brain, connective tissues, and the immune system. She stated that the cannabinoid receptors appear to have anti-inflammatory and pain-relieving properties. Her conclusion was that the cannabinoids seem to affect critical neurotransmitters, including serotonin and dopamine.
Borgelt also states,”We believe serotonin plays a role in migraine headaches, but we are still working to discover the exact role of cannabinoids in this condition.”
Borgelt’s overall conclusion was that the results were “quite remarkable,” but that they indicated the need for additional controlled studies in the future. She indicated that due to federal drug laws that the required type of study would likely require legislative changes before studies could be started in the United States.
Author: Jeffrey Friedland (email@example.com, Tel. 1-970-779-4040)
Jeffrey Friedland is the author of “Marijuana: The World’s Most Misunderstood Plant,” which is available in print and Kindle editions at Amazon (www.amazon.com/author/jeffreyfriedland)